Legacy Housing

Legacy Housing Corp builds, sells and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and are sold directly to manufactured home communities. It also provides consumer financing for its products which are sold to end-users through both independent and company-owned retail locations, and it provides financing to manufactured housing community owners that buy its products for use in their housing communities.

Legacy Housing Corporation - Common Stock

News

Tech

BlackBerry Awarded Four U.S. Patents: Method and System for Signaling Transmission Layers for Single User and Multi User Mimo; Reducing Network Security Risks in a Medical Care Network; Systems and Methods for Vehicle Condition Inspection for Shared Vehicles; Determining Motion of a Moveable Platform

Wells Fargo analyst Sarah Akers downgrades Evergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVRG#NYSE">EVRG</a>) from Overweight to Equal-Weight and announces $68 price target.

Downgrades

Price Target

Analyst Ratings

EVRG

Wells Fargo Downgrades Evergy to Equal-Weight, Announces $68 Price Target

What Happened: Morgan Stanley (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ms#NYSE">MS</a>) has made its first investment in the blockchain industry, co-leading a $48 million investment round in digital asset securities firm Securitize, Inc.
Blockchain Capital, Securitize&rsquo;s largest investor, also co-led the round along with Morgan Stanley&rsquo;s investment fund Morgan Stanley Tactical Value.
According to a <a href="https://www.prnewswire.com/news-releases/securitize-raises-48-million-in-series-b-capital-to-expand-its-leadership-in-digital-asset-securities-and-in-the-digitization-of-private-capital-markets-301316112.html" style="color:#0563c1; text-decoration:underline">press release</a>, Securitize&rsquo;s Series B funding round was oversubscribed, raising a total of $48 million from new and existing investors.
New investors included&nbsp;Ava Labs, IDC Ventures, Migration Capital, NTT Data, and Japan-based Sumitomo Mitsui Trust Bank, representing major institutional interest from North America,&nbsp;Europe, and the&nbsp;Asia-Pacific&nbsp;region.
Meanwhile, existing investors like&nbsp;Blockchain Ventures, Borderless Capital, Global Brain, Mouro Capital, Ripio, Ripple Labs, and SPiCE VC joined the round to increase their investment in the firm.
Why It Matters: Participants in the round will reportedly receive their shares in the form of digital asset securities issued by Securitize&#39;s platform.
&quot;Our first investment in the blockchain industry is the leading digital asset securities firm, Securitize. Securitize is well-recognized for pioneering the securitization of digital asset securities on the blockchain, and for its fully-compliant and fully-digital end-to-end solution that enables private companies to raise capital, and for investors to find a path to liquidity,&quot; said&nbsp;Pedro Teixeira, Co-Head of Morgan Stanley Tactical Value Investing.&nbsp;
Read also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21581876/morgan-stanley-adds-another-bitcoin-focused-fund-from-nydig-and-fs-investments">Morgan Stanley Adds Another Bitcoin-Focused Fund From NYDIG And FS Investments</a>
&quot;We make long-term investments in businesses and asset classes that are ahead of the curve. Our investment in Securitize is a sign that we believe in the growth and adoption of digital asset securities.&quot;
Teixeira will join Securitize&rsquo;s Board of Directors along with Blockchain Capital co-founder and Managing Partner Brad Stephens.
The raise also comes before the launch of Securitize Markets, a marketplace to facilitate the trading of digital asset securities, providing a path to liquidity for the private capital markets.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

Management

Markets

General

$BTC

Morgan Stanley Co-Leads $48M Funding Round In Coinbase-Backed Securitize

<a href="https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&amp;r=1008&amp;f=G&amp;l=50&amp;d=PTXT&amp;p=21&amp;S1=20210622&amp;OS=20210622&amp;RS=20210622" title="https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&amp;r=1008&amp;f=G&amp;l=50&amp;d=PTXT&amp;p=21&amp;S1=20210622&amp;OS=20210622&amp;RS=20210622">https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&amp;r=1008&amp;f=G&amp;l=50&amp;d=PTXT&amp;p=21&amp;S1=20210622&amp;OS=20210622&amp;RS=20210622</a>

TSLA

Tesla Awarded US Patent Titled 'System and method for facilitating conditioning and testing of rechargeable battery cells'

<ul>
<li>NextCure Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtc#NASDAQ">NXTC</a>) has&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/06/g21653262/nextcure-and-collaborators-publish-preclinical-data-on-novel-immunomedicine-nc410" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">published preclinical data for NC410</a>&nbsp;in the online journal eLife.</li>
<li>NC410 is currently being evaluated in a Phase 1/2 trial in patients with advanced or metastatic solid tumors. Initial data readout expected in half of 2021.</li>
<li>Data revealed that NC410 promotes T cell-mediated anti-tumor immunity and infiltration and localized activity of T cells in the tumor microenvironment, suggesting its potential both as monotherapy and combination treatment.</li>
<li>This publication demonstrated that NC410 binding was most notable in collagen-rich tumors, such as gastric, ovarian, lung, head &amp; neck, and regions where immune cells were excluded.&nbsp;</li>
<li>NC410 is a dimeric LAIR-2 Fc fusion protein designed to act as a LAIR-1 decoy by binding with higher affinity to tumoral collagens than human LAIR-1, preventing LAIR-1-mediated immune suppression.&nbsp;</li>
<li>Price Action: NXTC shares closed at $7.91 on Monday.</li>
</ul>

Biotech

Health Care

NXTC

NextCure's Immunomedicine NC410 Shows Promising Anti-Cancer Activity In Preclinical Studies

Goldman Sachs analyst Bonnie Herzog downgrades Casey's General Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>) from Buy to Neutral and lowers the price target from $240 to $215.

CASY

Goldman Sachs Downgrades Casey's General Stores to Neutral, Lowers Price Target to $215

<ul>
<li>Company outlines significant value creation potential to contribute to the diagnosis of rare diseases and to enable the development of novel therapeutics</li>
<li>Focuses on leveraging its unique rare disease-centric Bio/Databank to accelerate orphan drug development in partnership with bio-/pharmaceutical companies</li>
<li>Clear priorities set for therapeutic disease areas, focusing on rare neurological (CNS) and metabolic disorders</li>
<li>Mid-term targets set to reach 1 million patients in Bio/Databank and 10 full disease models for rare disease R&amp;D partnering</li>
</ul>
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 22, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTG#NASDAQ">CNTG</a>), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, will hold its first Virtual Investor Event, presented by its newly formed executive team.
Andrin Oswald, M.D., Chief Executive Officer at CENTOGENE, stated, &quot;Over the past 15 years, CENTOGENE has built a unique expertise and has become the leading data-driven insights provider purely focused on rare genetic diseases. We are now embarking on our next growth phase &ndash; enabling the cure of 100 rare diseases within the next 10 years. This represents the potential to significantly contribute to reducing the burden of rare diseases.&quot;
&quot;This next chapter is powered by our unparalleled genomics knowledge, the world&#39;s largest rare disease-centric Bio/Databank, global footprint, and strong established network of physicians, partners, and patients. Together with our AI and multiomic tools, this puts us at the focal point of precision medicine for genetically linked rare diseases &ndash; driven by the ability to unlock the complexities of patients&#39; biology to diagnose, understand, and treat these diseases effectively. As the rare disease market is vast and often overlooked, and as our capabilities will contribute significantly to the sector, we believe that this new focus will offer substantial possibilities for value creation.&quot;
Diagnose. Understand. Treat.
Founded in 2006, CENTOGENE has long been known for its expertise in the field of rare disease genetics &ndash; helping over 600,000 patients and building a rare disease-centric Bio/Databank. Aspiring to reduce the heavy burden of rare diseases through data-driven insights, the Company has established itself as the leading partner of choice for patients, physicians, and pharma partners.
At the Virtual Investor Event, the Company will announce its strategic multi-pronged approach to diagnose, understand, and treat rare diseases by finding, connecting, and investigating patients and their biology from around the world.
Strategic Priorities to Accelerate the Discovery, Development, and Access to Orphan Drugs
<ul>
<li>Focus on building the Company&#39;s Bio/Databank with multimodal data for prioritized disease areas; mid-term target of over 1 million patients</li>
<li>Further establish multiomic platform to overcome the diverse challenges of diagnostics, patient identification, clinical trials, and drug discovery and development</li>
<li>Develop 10 full disease models, including cell lines within the mid-term</li>
<li>Partner in therapeutic focus areas, including two major strategic partnership deals towards enabling therapy development within the next years</li>
<li>Initial priority diseases in the areas of metabolic and neurological disorders include Gaucher and genetic Parkinson&#39;s disease 
	&nbsp;</li>
</ul>
While the Company continues to drive targeted innovation, its priorities remain the same: investing and building its Diagnostics and Pharma segments to transform the science of clinical and genetic data into medical solutions for rare disease patients.
In both of CENTOGENE&#39;s core business segments, the Company has established unique positioning and has laid the foundation for growth and impact expected in the near-, mid-, and long-term. Leveraging its rare disease expertise while expanding technology capabilities, CENTOGENE is confident about its path to enabling the cure of 100 rare diseases.
Register for the Virtual&nbsp;Investor&nbsp;Event
The Company will be hosting the Virtual Investor Event today, June 22, 2021, at 9:00 a.m. - 11:00 a.m. EDT / 3:00 p.m. - 5:00 p.m. CEST. To register visit:&nbsp;<a href="https://www.centogene.com/virtual-investor-event.html">https://www.centogene.com/virtual-investor-event.html</a>
Participants may also access the conference call by dialing U.S. toll free +1 855 979 6654 or U.K.&nbsp;+44 (0) 800 640 6441 up to 10 minutes prior to the start of the call and by providing the conference ID number 182810. Other participant dial-in numbers can be found on the event&#39;s registration page.

Events

CNTG

CENTOGENE Announces Investor Event Jun. 22 At 9:00 a.m. EDT

<ul>
<li>Sanofi Pasteur, vaccine unit of&nbsp;Sanofi SA&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sny#NASDAQ">SNY</a>) and&nbsp;Translate Bio Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tbio#NASDAQ">TBIO</a>) have&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/06/g21658313/sanofi-and-translate-bio-initiate-phase-1-clinical-trial-of-mrna-influenza-vaccine" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">initiated a Phase 1 trial</a>&nbsp;evaluating an mRNA-based investigational vaccine against seasonal influenza.</li>
<li>The 280-subject trial will assess the safety and immunogenicity (immune response) of the monovalent (single-strain) mRNA-based flu vaccine candidate.</li>
<li>The trial will evaluate several dose levels of both vaccine formulations given to healthy adults 18 - 49 years of age.</li>
<li>Interim data from the trial is expected by the end of 2021.</li>
<li>Sanofi and Translate Bio have developed and will evaluate two formulations of the vaccine (MRT5400 and MRT5401) in the Phase 1 influenza mRNA vaccine clinical trial.&nbsp;</li>
<li>The two formulations differ in the lipid nanoparticle that contains the mRNA.</li>
<li>Preclinical results were shared previously at the annual mRNA Healthcare Conference in November 2020.</li>
<li>Under the collaboration, in March, the companies&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/general/biotech/21/03/20137501/sanofi-translate-bio-initiate-human-trial-of-mrna-covid-19-vaccine-candidate" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">initiated a Phase 1/2 trial</a>&nbsp;of their mRNA COVID-19 vaccine candidate.</li>
<li>Earlier, Translate Bio also&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/06/g21447670/translate-bio-achieves-manufacturing-milestone-related-to-influenza-mrna-vaccine-program" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">received a $50 million manufacturing milestone</a>&nbsp;under the collaboration related to its influenza mRNA vaccine program.&nbsp;</li>
<li>Price Action:&nbsp;TBIO shares closed at $18.74 on Monday.</li>
</ul>

Contracts

Small Cap

TBIO

Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial

Baird analyst Mircea Dobre downgrades Welbilt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBT#NYSE">WBT</a>) from Outperform to Neutral and announces $26 price target.

Baird Downgrades Welbilt to Neutral, Announces $26 Price Target

Repligen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Toulouse, France based Polymem S.A. (&ldquo;Polymem&rdquo;), a leading industrial expert in the development and manufacture of hollow fiber membranes and modules.
Tony J. Hunt, President and CEO of Repligen, said, &ldquo;We are delighted to have Jean-Michel, Franc and the Polymem team join the Repligen family. The acquisition significantly expands our hollow fiber membrane and module production capabilities and adds core R&amp;D, engineering and production expertise in hollow fiber technology for both industrial and bioprocessing markets. The business complements what we have already in place at our Rancho Dominguez site and establishes a world-class center of excellence in Europe to meet the accelerating demand for hollow fiber products and to serve our rapidly expanding global customer base.&rdquo;
Jean-Michel Espenan, President of Polymem, said, &ldquo;Since co-founding the company in 1997, Polymem has remained true to our expertise in hollow fiber membrane development and manufacturing for industrial and life sciences applications. By joining forces with Repligen, we now have the opportunity to focus on two market segments, Municipal/Industrial and Bioprocessing, each with very similar needs and demands. This deal further extends our market reach, allowing us to boost our growth across both our historical Municipal/Industrial markets and the Bioprocessing market. We continue to increase capacity with the extension of our production site in Castanet-Tolosan, south of Toulouse, and we look forward to working together with Repligen to further penetrate our core markets.&rdquo;
Jean-Michel Espenan and Franc Saux will stay on with the company in their current respective roles of President and Technical Director. The proposed acquisition is expected to close during Repligen&rsquo;s third fiscal quarter of 2021, subject to the satisfaction of customary closing conditions. To fund the transaction, Repligen intends to use its cash on hand which totaled approximately $711 million at March 31, 2021. Additional financial details were not disclosed. Perella Weinberg Partners LP is acting as financial advisor and Goodwin Procter LLP is serving as legal counsel to Repligen.

RGEN

Repligen Corporation Announces Agreement To Acquire Polymem S.A.; Size Of Deal Not Disclosed

National Bank Of Canada initiates coverage on Integra Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITRG#AMEX">ITRG</a>) with a Outperform rating.

Initiation

ITRG

National Bank Of Canada Initiates Coverage On Integra Resources with Outperform Rating

<ul>
<li>GlaxoSmithKline plc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gsk#NYSE">GSK</a>),&nbsp;Pfizer Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>), and&nbsp;Shionogi Limited&nbsp;owned&nbsp;ViiV Healthcare&nbsp;has collaborated with&nbsp;Halozyme Therapeutics Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/halo#NASDAQ">HALO</a>) to gain access to Halozyme&#39;s Enhanze drug delivery technology for use against four HIV targets.</li>
<li>ViiV Healthcare will pay&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/06/b21658670/viiv-healthcare-and-halozyme-enter-global-collaboration-and-license-agreement-for-enhanze-drug-del" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">$40 million upfront and up to $175 million in milestones</a>, as well as mid-single-digit royalties on future sales.</li>
<li>Enhanze technology uses a recombinant human hyaluronidase PH20 enzyme to temporarily break down a barrier under the skin to allow large amounts of fluid to be injected into the subcutaneous space.&nbsp;</li>
<li>Therefore, drugs that are otherwise given in high doses by intravenous injections could be converted into subcutaneous injectables, offering convenience for patients.</li>
<li>Plans are underway to initiate the first experiments with the technology by the end of 2021 for investigational, long-acting cabotegravir to prevent HIV, which is currently administered every two months.</li>
<li>Price Action:&nbsp;HALO shares closed at $42.17 on Monday.</li>
</ul>

HALO

GSK- Pfizer's ViiV To Develop 'Ultra-Long-Acting' HIV Drugs With $215M Halozyme Deal

Cowen &amp; Co. analyst Oliver Chen upgrades Sally Beauty Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) from Market Perform to Outperform and announces $30 price target.

Upgrades

Cowen & Co. Upgrades Sally Beauty Holdings to Outperform, Announces $30 Price Target

National Bank Of Canada downgrades Kinross Gold (TSX:<a class="ticker" href="https://www.benzinga.com/stock/K#TSX">K</a>) from Outperform to Sector Perform and lowers the price target from C$15 to C$10.

TSX:K

National Bank Of Canada Downgrades Kinross Gold to Sector Perform, Lowers Price Target to C$10

<a href="https://twitter.com/ElectrekCo/status/1407281240894590979" title="https://twitter.com/ElectrekCo/status/1407281240894590979">https://twitter.com/ElectrekCo/status/1407281240894590979</a>

'Tesla signs deal with new home builder to outfit whole community with solar, Powerwall, and chargers' -Electrek

EGHT

8 X 8 Awarded Four U.S. Patents: Multi-level Programming/data Sets With Decoupling Voip Communications Interface; Customization of Alerts Using Telecommunications Services; Dynamic Direction of Incoming Calls; Server-presented Inquiries Using Specific Context From Previous Communications

Oppenheimer analyst Bryan Blair upgrades Lincoln Electric Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LECO#NASDAQ">LECO</a>) from Perform to Outperform and announces $147 price target.

LECO

Oppenheimer Upgrades Lincoln Electric Holdings to Outperform, Announces $147 Price Target

Loop Capital analyst Garik Shmois upgrades American Woodmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMWD#NASDAQ">AMWD</a>) from Hold to Buy and announces $100 price target.

AMWD

Loop Capital Upgrades American Woodmark to Buy, Announces $100 Price Target

Stephens &amp; Co. analyst Vincent Caintic initiates coverage on Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Underweight rating and announces Price Target of $55.

AFRM

Stephens & Co. Initiates Coverage On Affirm Holdings with Underweight Rating, Announces Price Target of $55

Loop Capital analyst Garik Shmois upgrades Fortune Brands Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBHS#NYSE">FBHS</a>) from Hold to Buy and announces $100 price target.

FBHS

Loop Capital Upgrades Fortune Brands Home to Buy, Announces $100 Price Target

B. Riley FBR maintains Legacy Housing (NASDAQ:<a class="ticker" href="/stock/LEGH#NASDAQ">LEGH</a>) with a Neutral and raises the price target from $10 to $13.

B. Riley FBR Maintains Neutral on Legacy Housing, Raises Price Target to $13

<h3>Gainers</h3>

<ul>
	<li>Kaixin Auto Hldgs (NASDAQ:<a class="ticker" href="/stock/KXIN#NASDAQ">KXIN</a>) stock rose 122.38% to $1.22 during Wednesday&#39;s regular session. The current volume of 3.4 million shares is 2264.33% of Kaixin Auto Hldgs&#39;s average full-day volume over the last 100 days (last updated at 12:31 EST). The company&#39;s market cap stands at $74.8 million.</li>
	<li>NIO (NYSE:<a class="ticker" href="/stock/NIO#NYSE">NIO</a>) stock increased by 20.0% to $25.94. As of 12:31 EST, this security is trading at a volume of 248.6 million shares, making up 233.1% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $27.6 billion.</li>
	<li>Electrameccanica Vehicles (NASDAQ:<a class="ticker" href="/stock/SOLO#NASDAQ">SOLO</a>) shares increased by 11.91% to $3.1. As of 12:31 EST, Electrameccanica Vehicles&#39;s stock is trading at a volume of 24.8 million, which is 416.56% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $118.7 million.</li>
	<li>Betterware de Mexico SAB (NASDAQ:<a class="ticker" href="/stock/BWMX#NASDAQ">BWMX</a>) stock increased by 10.3% to $24.2. As of 12:31 EST, Betterware de Mexico SAB&#39;s stock is trading at a volume of 109.3K, which is 144.25% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $833.7 million.</li>
	<li>Li Auto Inc (NASDAQ:<a class="ticker" href="/stock/LI#NASDAQ">LI</a>) stock moved upwards by 8.56% to $21.09. The current volume of 10.3 million shares is 115.75% of Li Auto Inc&#39;s average full-day volume over the last 100 days (last updated at 12:31 EST).</li>
	<li>XPeng (NYSE:<a class="ticker" href="/stock/XPEV#NYSE">XPEV</a>) stock rose 8.56% to $21.29. Trading volume for XPeng&#39;s stock is 11.4 million as of 12:31 EST. This is 162.03% of its average full-day volume over the last 100 days.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

<ul>
	<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="/stock/LAZY#NASDAQ">LAZY</a>) shares decreased by 15.15% to $14.26 during Wednesday&#39;s regular session. As of 12:31 EST, Lazydays Holdings&#39;s stock is trading at a volume of 627.0K, which is 310.28% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $119.5 million.</li>
	<li>J.Jill (NYSE:<a class="ticker" href="/stock/JILL#NYSE">JILL</a>) stock fell 14.96% to $0.75. J.Jill&#39;s stock is trading at a volume of 1.8 million shares as of 12:31 EST. This is 44.93% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $33.2 million.</li>
	<li>FAT Brands (NASDAQ:<a class="ticker" href="/stock/FAT#NASDAQ">FAT</a>) stock decreased by 8.95% to $5.6. FAT Brands&#39;s stock is trading at a volume of 26.9K shares as of 12:31 EST. This is 4.88% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $66.6 million.</li>
	<li>LightInTheBox Holding (NYSE:<a class="ticker" href="/stock/LITB#NYSE">LITB</a>) stock declined by 7.82% to $2.36. Trading volume for LightInTheBox Holding&#39;s stock is 244.8K as of 12:31 EST. This is 25.06% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $263.7 million.</li>
	<li>Legacy Housing (NASDAQ:<a class="ticker" href="/stock/LEGH#NASDAQ">LEGH</a>) shares fell 7.72% to $15.32. The current volume of 34.5K shares is 104.45% of Legacy Housing&#39;s average full-day volume over the last 100 days (last updated at 12:31 EST). The market value of their outstanding shares is at $379.3 million.</li>
	<li>XPEL (NASDAQ:<a class="ticker" href="/stock/XPEL#NASDAQ">XPEL</a>) shares fell 7.33% to $26.95. Trading volume for XPEL&#39;s stock is 641.0K as of 12:31 EST. This is 255.75% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $744.1 million.</li>
</ul>

&nbsp;

&nbsp;

Intraday Update

Movers

12 Consumer Cyclical Stocks Moving In Wednesday's Intraday Session

Trading Ideas

Stocks That Hit 52-Week Highs On Monday

B. Riley FBR analyst Alex Rygiel upgrades Legacy Housing (NASDAQ:<a class="ticker" href="/stock/LEGH#NASDAQ">LEGH</a>) from Neutral to Buy and announces $20 price target.

B. Riley FBR Upgrades Legacy Housing to Buy, Announces $20 Price Target

WIIM

Legacy Housing shares are trading higher after B. Riley FBR upgraded the stock from Neutral to Buy and announced a price target of $20 per share.

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021

&nbsp;

<h1>&nbsp;</h1>

During Tuesday&#39;s morning trading, 67 companies set new 52-week highs.

<h2>Points of Interest:</h2>

<ul>
	<li>The largest company by market cap to hit a new 52-week high was UnitedHealth Group (NYSE:<a class="ticker" href="/stock/UNH#NYSE">UNH</a>).</li>
	<li>Schmitt Industries (NASDAQ:<a class="ticker" href="/stock/SMIT#NASDAQ">SMIT</a>) was the smallest Company by market cap to set a new 52-week high.</li>
	<li>Dolphin Entertainment (NASDAQ:<a class="ticker" href="/stock/DLPN#NASDAQ">DLPN</a>) rallied the most, trading up 164.97% to reach its new 52-week high.</li>
</ul>

During the first half-hour of trading on Tuesday, the following stocks set new 52-week highs:

<ul>
	<li>UnitedHealth Group (NYSE:<a class="ticker" href="/stock/UNH#NYSE">UNH</a>) shares broke to $370.68 on Tuesday, setting a new 52-week high with a change of up 0.77%.</li>
	<li>Home Depot (NYSE:<a class="ticker" href="/stock/HD#NYSE">HD</a>) stock hit a yearly high price of $293.43. The stock was up 0.99% for the day.</li>
	<li>Cisco Systems (NASDAQ:<a class="ticker" href="/stock/CSCO#NASDAQ">CSCO</a>) stock made a new 52-week high of $50.68 Tuesday. The stock was up 0.14% for the day.</li>
	<li>Texas Instruments (NASDAQ:<a class="ticker" href="/stock/TXN#NASDAQ">TXN</a>) shares hit a yearly high of $182.57. The stock traded down 0.15% on the session.</li>
	<li>Lowe&#39;s Companies (NYSE:<a class="ticker" href="/stock/LOW#NYSE">LOW</a>) shares set a new 52-week high of $183.79 on Tuesday, moving up 0.36%.</li>
	<li>Tencent Music Enter Gr (NYSE:<a class="ticker" href="/stock/TME#NYSE">TME</a>) shares broke to $32.25 on Tuesday, setting a new 52-week high with a change of up 2.59%.</li>
	<li>Keurig Dr Pepper (NASDAQ:<a class="ticker" href="/stock/KDP#NASDAQ">KDP</a>) shares were up 0.61% on Tuesday morning to hit a new 52-week high of $34.94.</li>
	<li>Hershey (NYSE:<a class="ticker" href="/stock/HSY#NYSE">HSY</a>) shares reached a new 52-week high of $157.20 on Tuesday morning, moving up 0.19%.</li>
	<li>Motorola Solutions (NYSE:<a class="ticker" href="/stock/MSI#NYSE">MSI</a>) stock on Tuesday broke to a yearly high of $187.40. Shares traded up 0.4%.</li>
	<li>Vipshop Holdings (NYSE:<a class="ticker" href="/stock/VIPS#NYSE">VIPS</a>) shares hit $45.76 on Tuesday morning, setting a new 52-week high for a change of up 0.8%.</li>
	<li>McKesson (NYSE:<a class="ticker" href="/stock/MCK#NYSE">MCK</a>) shares were down 1.09% for the day, having made a 52-week high of $193.24.</li>
	<li>AutoZone (NYSE:<a class="ticker" href="/stock/AZO#NYSE">AZO</a>) shares broke to a new 52-week high of $1,353.29 on Tuesday. Shares of the company traded down 0.67%.</li>
	<li>iQIYI (NASDAQ:<a class="ticker" href="/stock/IQ#NASDAQ">IQ</a>) shares were up 1.71% on Tuesday to hit a new 52-week high of $28.80 for a change of up 1.71%.</li>
	<li>CGI (NYSE:<a class="ticker" href="/stock/GIB#NYSE">GIB</a>) shares broke to a new 52-week high of $83.53 on Tuesday. Shares of the company traded up 0.83%.</li>
	<li>Tractor Supply (NASDAQ:<a class="ticker" href="/stock/TSCO#NASDAQ">TSCO</a>) stock hit a yearly high price of $176.82. The stock was up 1.62% for the day.</li>
	<li>Nomura Holdings (NYSE:<a class="ticker" href="/stock/NMR#NYSE">NMR</a>) shares set a new 52-week high of $6.54 on Tuesday, moving up 0.31%.</li>
	<li>Liberty Global (NASDAQ:<a class="ticker" href="/stock/LBTYA#NASDAQ">LBTYA</a>) stock made a new 52-week high of $27.04 Tuesday. The stock was down 0.22% for the day.</li>
	<li>Williams-Sonoma (NYSE:<a class="ticker" href="/stock/WSM#NYSE">WSM</a>) stock hit a yearly high price of $184.32. The stock was down 0.07% for the day.</li>
	<li>A.O. Smith (NYSE:<a class="ticker" href="/stock/AOS#NYSE">AOS</a>) shares set a new 52-week high of $68.47 on Tuesday, moving down 0.99%.</li>
	<li>Berry Global Group (NYSE:<a class="ticker" href="/stock/BERY#NYSE">BERY</a>) shares reached a new 52-week high of $61.96 on Tuesday morning, moving up 2.77%.</li>
	<li>Owl Rock Capital (NYSE:<a class="ticker" href="/stock/ORCC#NYSE">ORCC</a>) shares broke to a new 52-week high of $14.35 on Tuesday. Shares of the company traded up 0.69%.</li>
	<li>Diodes (NASDAQ:<a class="ticker" href="/stock/DIOD#NASDAQ">DIOD</a>) shares hit a yearly high of $91.02. The stock traded down 5.21% on the session.</li>
	<li>Extended Stay America (NASDAQ:<a class="ticker" href="/stock/STAY#NASDAQ">STAY</a>) shares broke to a new 52-week high of $20.03 on Tuesday. Shares of the company traded up 1.12%.</li>
	<li>Organogenesis Holdings (NASDAQ:<a class="ticker" href="/stock/ORGO#NASDAQ">ORGO</a>) shares hit $21.75 on Tuesday morning, setting a new 52-week high for a change of down 0.71%.</li>
	<li>At Home Group (NYSE:<a class="ticker" href="/stock/HOME#NYSE">HOME</a>) stock set a new 52-week high of $34.42 Tuesday morning. Over the session, the stock traded down 5.61%.</li>
	<li>Columbia Financial (NASDAQ:<a class="ticker" href="/stock/CLBK#NASDAQ">CLBK</a>) shares were up 0.5% on Tuesday morning to hit a new 52-week high of $18.05.</li>
	<li>Alphatec Holdings (NASDAQ:<a class="ticker" href="/stock/ATEC#NASDAQ">ATEC</a>) shares hit a new 52-week high of $19.36. The stock traded down 2.29% on the session.</li>
	<li>Vuzix (NASDAQ:<a class="ticker" href="/stock/VUZI#NASDAQ">VUZI</a>) shares were up 0.64% on Tuesday morning to hit a new 52-week high of $30.65.</li>
	<li>Lantheus Holdings (NASDAQ:<a class="ticker" href="/stock/LNTH#NASDAQ">LNTH</a>) shares hit $20.68 on Tuesday morning, setting a new 52-week high for a change of up 0.56%.</li>
	<li>BioLife Solutions (NASDAQ:<a class="ticker" href="/stock/BLFS#NASDAQ">BLFS</a>) shares reached a new 52-week high of $47.95 on Tuesday morning, moving up 8.67%.</li>
	<li>Ingles Markets (NASDAQ:<a class="ticker" href="/stock/IMKTA#NASDAQ">IMKTA</a>) shares set a new yearly high of $64.41 this morning. The stock was up 0.85% on the session.</li>
	<li>Five Point Holdings (NYSE:<a class="ticker" href="/stock/FPH#NYSE">FPH</a>) shares set a new 52-week high of $8.56 on Tuesday, moving down 0.07%.</li>
	<li>Radius Health (NASDAQ:<a class="ticker" href="/stock/RDUS#NASDAQ">RDUS</a>) stock set a new 52-week high of $26.06 Tuesday morning. Over the session, the stock traded up 0.5%.</li>
	<li>Nuveen NASDAQ 100 Dynamic (NASDAQ:<a class="ticker" href="/stock/QQQX#NASDAQ">QQQX</a>) stock on Tuesday broke to a yearly high of $27.90. Shares traded up 0.04%.</li>
	<li>NeoGames (NASDAQ:<a class="ticker" href="/stock/NGMS#NASDAQ">NGMS</a>) shares hit $43.64 on Tuesday morning, setting a new 52-week high for a change of down 0.4%.</li>
	<li>Trean Insurance Group (NASDAQ:<a class="ticker" href="/stock/TIG#NASDAQ">TIG</a>) stock on Tuesday broke to a yearly high of $19.57. Shares traded up 4.41%.</li>
	<li>PIMCO High Income Fund (NYSE:<a class="ticker" href="/stock/PHK#NYSE">PHK</a>) stock made a new 52-week high of $6.55 Tuesday. The stock was up 0.77% for the day.</li>
	<li>Gannett Co (NYSE:<a class="ticker" href="/stock/GCI#NYSE">GCI</a>) shares hit $6.33 on Tuesday morning, setting a new 52-week high for a change of down 0.09%.</li>
	<li>Takung Art Co., Ltd. Common Stock (AMEX:<a class="ticker" href="/stock/TKAT#AMEX">TKAT</a>) shares were up 30.64% on Tuesday to hit a new 52-week high of $74.11 for a change of up 30.64%.</li>
	<li>Aemetis (NASDAQ:<a class="ticker" href="/stock/AMTX#NASDAQ">AMTX</a>) shares hit a new 52-week high of $26.26. The stock traded up 10.64% on the session.</li>
	<li>Global Ship Lease (NYSE:<a class="ticker" href="/stock/GSL#NYSE">GSL</a>) stock set a new 52-week high of $17.85 Tuesday morning. Over the session, the stock traded down 10.27%.</li>
	<li>Orchid Island Capital (NYSE:<a class="ticker" href="/stock/ORC#NYSE">ORC</a>) shares broke to $6.11 on Tuesday, setting a new 52-week high with a change of up 0.5%.</li>
	<li>John Hancock Preferred (NYSE:<a class="ticker" href="/stock/HPS#NYSE">HPS</a>) shares set a new yearly high of $17.55 this morning. The stock was up 0.21% on the session.</li>
	<li>Evolus (NASDAQ:<a class="ticker" href="/stock/EOLS#NASDAQ">EOLS</a>) shares were up 13.36% for the day, having made a 52-week high of $16.34.</li>
	<li>Daseke (NASDAQ:<a class="ticker" href="/stock/DSKE#NASDAQ">DSKE</a>) shares hit $7.90 on Tuesday morning, setting a new 52-week high for a change of down 2.42%.</li>
	<li>Legacy Housing (NASDAQ:<a class="ticker" href="/stock/LEGH#NASDAQ">LEGH</a>) shares were up 3.43% for the day, having made a 52-week high of $18.70.</li>
	<li>LiveXLive Media (NASDAQ:<a class="ticker" href="/stock/LIVX#NASDAQ">LIVX</a>) shares hit $6.10 on Tuesday morning, setting a new 52-week high for a change of up 10.92%.</li>
	<li>Star Group (NYSE:<a class="ticker" href="/stock/SGU#NYSE">SGU</a>) stock made a new 52-week high of $10.50 Tuesday. The stock was up 1.88% for the day.</li>
	<li>Natures Sunshine Products (NASDAQ:<a class="ticker" href="/stock/NATR#NASDAQ">NATR</a>) shares were down 0.15% on Tuesday morning to hit a new 52-week high of $21.36.</li>
	<li>Soliton (NASDAQ:<a class="ticker" href="/stock/SOLY#NASDAQ">SOLY</a>) shares set a new 52-week high of $19.62 on Tuesday, moving up 9.28%.</li>
	<li>Oramed Pharmaceuticals (NASDAQ:<a class="ticker" href="/stock/ORMP#NASDAQ">ORMP</a>) shares broke to $12.73 on Tuesday, setting a new 52-week high with a change of up 3.94%.</li>
	<li>Saratoga Investment (NYSE:<a class="ticker" href="/stock/SAR#NYSE">SAR</a>) shares reached a new 52-week high of $24.50 on Tuesday morning, moving down 0.51%.</li>
	<li>Eaton Vance Municipal (NYSE:<a class="ticker" href="/stock/ETX#NYSE">ETX</a>) shares were down 2.73% on Tuesday morning to hit a new 52-week high of $25.45.</li>
	<li>Stratus Properties (NASDAQ:<a class="ticker" href="/stock/STRS#NASDAQ">STRS</a>) shares broke to $29.93 on Tuesday, setting a new 52-week high with a change of up 1.89%.</li>
	<li>Pacific Mercantile (NASDAQ:<a class="ticker" href="/stock/PMBC#NASDAQ">PMBC</a>) stock on Tuesday broke to a yearly high of $9.15. Shares traded up 11.66%.</li>
	<li>Farmer Bros (NASDAQ:<a class="ticker" href="/stock/FARM#NASDAQ">FARM</a>) shares achieved a new 52-week high on Tuesday morning, hitting $11.60 with a daily change of up 2.86%.</li>
	<li>Townsquare Media (NYSE:<a class="ticker" href="/stock/TSQ#NYSE">TSQ</a>) stock set a new 52-week high of $12.51 Tuesday morning. Over the session, the stock traded down 4.25%.</li>
	<li>USA Truck (NASDAQ:<a class="ticker" href="/stock/USAK#NASDAQ">USAK</a>) shares hit a new 52-week high of $19.10. The stock traded down 7.41% on the session.</li>
	<li>US Global Investors (NASDAQ:<a class="ticker" href="/stock/GROW#NASDAQ">GROW</a>) shares were up 3.13% for the day, having made a 52-week high of $8.65.</li>
	<li>Sound Financial Bancorp (NASDAQ:<a class="ticker" href="/stock/SFBC#NASDAQ">SFBC</a>) stock on Tuesday broke to a yearly high of $42.90. Shares traded up 2.17%.</li>
	<li>Dolphin Entertainment (NASDAQ:<a class="ticker" href="/stock/DLPN#NASDAQ">DLPN</a>) shares achieved a new 52-week high on Tuesday morning, hitting $16.31 with a daily change of up 164.97%.</li>
	<li>Volt Information Sciences, Inc. Common Stock (AMEX:<a class="ticker" href="/stock/VOLT#AMEX">VOLT</a>) shares hit a new 52-week high of $3.88. The stock traded up 3.62% on the session.</li>
	<li>Quest Resource Holding (NASDAQ:<a class="ticker" href="/stock/QRHC#NASDAQ">QRHC</a>) shares were down 4.43% on Tuesday morning to hit a new 52-week high of $4.07.</li>
	<li>PermRock Royalty Trust (NYSE:<a class="ticker" href="/stock/PRT#NYSE">PRT</a>) shares set a new yearly high of $5.95 this morning. The stock was up 0.7% on the session.</li>
	<li>Liquid Media Group (NASDAQ:<a class="ticker" href="/stock/YVR#NASDAQ">YVR</a>) shares achieved a new 52-week high on Tuesday morning, hitting $7.50 with a daily change of up 48.43%.</li>
	<li>Hudson Global (NASDAQ:<a class="ticker" href="/stock/HSON#NASDAQ">HSON</a>) stock made a new 52-week high of $18.13 Tuesday. The stock was down 4.0% for the day.</li>
	<li>Schmitt Industries (NASDAQ:<a class="ticker" href="/stock/SMIT#NASDAQ">SMIT</a>) shares were down 0.46% on Tuesday to hit a new 52-week high of $6.76 for a change of down 0.46%.</li>
</ul>

&nbsp;

Stay with Benzinga for further updates about these companies and many others going forward.

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-12
REV		(EXPECTED)2021-08-12

Q1 2021		Est.		Actual		Surprise
EPS				0.370
REV				39.900M

Recent Quotes

Earnings

Analyst Ratings

Related Companies

Legacy Housing Frequently Asked Questions

How do I buy Legacy Housing (LEGH) stock?

Who are Legacy Housing's (LEGH) competitors?

What is the target price for Legacy Housing (LEGH) stock?

Current Stock Price for Legacy Housing (LEGH)?

Does Legacy Housing (LEGH) pay a dividend?

When is Legacy Housing (NASDAQ:LEGH) reporting earnings?

Is Legacy Housing (LEGH) going to split?

What sector and industry does Legacy Housing (LEGH) operate in?